Pilot study on molecular quantitation and sequencing of endometrial cytokines gene expression and their effect on the outcome of in vitro fertilization (IVF) cycle  by Sabry, D. et al.
Journal of Advanced Research (2014) 5, 595–600Cairo University
Journal of Advanced ResearchORIGINAL ARTICLEPilot study on molecular quantitation and
sequencing of endometrial cytokines gene
expression and their eﬀect on the outcome
of in vitro fertilization (IVF) cycleAbbreviations: IL-11, interleukin 11; IL-11Ra, interleukin recep-
tor a; LIF, leukemia inhibitory factor; IVF, in vitro fertilization;
FSH, follicular stimulating hormone; LH, Luteinizing hormone; E2,
Estradiol 2.
* Corresponding author. Tel.: +20 1111200200.
E-mail address: dinnasabry69@yahoo.com (D. Sabry).
1 These authors are equally contributed to this work.
Peer review under responsibility of Cairo University.
Production and hosting by Elsevier
2090-1232 ª 2013 Production and hosting by Elsevier B.V. on behalf of Cairo University.
http://dx.doi.org/10.1016/j.jare.2013.08.003D. Sabry a,*,1, O. Nouh b,1, S. Marzouk a, A. Hassouna aa Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Egypt
b Department of Obstetrics and Gynaecology, Faculty of Medicine, Cairo University, EgyptA R T I C L E I N F O A B S T R A C TArticle history:
Received 11 May 2013
Received in revised form 23 July 2013
Accepted 18 August 2013
Available online 22 August 2013
Keywords:
Interleukin-11 (IL-11)
Interleukin-11 receptor a (IL-11Ra)
Leukemia inhibitory factor (LIF)
IVF
DNA sequenceHuman trophoblast invasion and differentiation are essential for successful pregnancy outcome.
The molecular mechanisms, however, are poorly understood. Interleukin (IL)-11, a cytokine,
regulates endometrial epithelial cell adhesion. Leukemia inhibitory factor (LIF) is one of the
key cytokines in the embryo implantation regulation. The present study aimed to assess the lev-
els of LIF, IL-11, and IL-11 a receptor gene expression in the endometrium of women under-
going IVF and correlate their levels with the IVF pregnancy outcome. Also, the study aimed
to detect any mutation in these three genes among IVF pregnant and non-pregnant women ver-
sus control menstrual blood of fertile women. Endometrial tissue biopsies were taken from 15
women undergoing IVF on the day of oocyte retrieval. The quantitative expression of IL-11, IL-
11Ra, and LIF genes was assessed by real-time PCR and PCR products were sequenced. Men-
strual blood from 10 fertile women was used as control to compare the DNA sequence versus
DNA sequence of the studied genes in endometrial biopsies. LH, FSH, and E2 were assessed for
enrolled patients by ELISA. Endometrial thickness was also assessed by pelvic ultrasonography.
No signiﬁcant difference was detected between quantitative expression of the three studied genes
and pregnancy IVF outcome. Although DNA sequence changes were found in IL-11 and LIF
genes of women with negative pregnancy IVF outcome compared to women with positive preg-
nancy IVF outcome, no DNA sequence changes were detected for IL-11Ra. Other studied
596 D. Sabry et al.parameters (e.g., age, LH, FSH, E2, and endometrial thickness) showed no signiﬁcant
differences or correlation of quantitative expression of the three studied involved genes. Data
suggested that there were no signiﬁcant differences between quantitative expression of IL-11,
IL-11Ra, and LIF genes and the IVF pregnancy outcome. The present study may reveal that
changes in IL-11 and LIF genes sequence may contribute in pregnancy IVF outcome.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Cairo University.Introduction
Embryo implantation is a complex process requiring synchro-
nized endometrial receptivity and blastocyst competence [1].
The initial apposition, attachment, and adhesion of the blasto-
cyst to an adequately prepared or receptive maternal endome-
trium occur via a coordinated dialog of locally produced
molecules, including cytokines, adhesion, and extracellular
matrix (ECM) molecules [2].
A class of cytokines, which play an important role in
embryonic implantation, is the interleukin-(IL) 6 superfamily.
That family consists of numerous cytokines, including leuke-
mia inhibitory factor (LIF), IL-6, interleukin-11 (IL-11), neu-
rotrophic factor, oncostatin-M, and cardiotrophin-1. An
important characteristic of that class of cytokines is their shar-
ing of intracellular signaling through gp130 [3]. IL-11 and LIF
signal via a hetero-dimeric receptor complex comprising either
the speciﬁc IL-11 receptor a chain or the low-afﬁnity LIF
receptor, associated with the common signaling component
gp130. Binding of IL-11 or LIF to their receptors forms a com-
plex that signals via activation of Janus kinases (JAKs) that
subsequently phosphorylate tyrosine residues in the cytoplas-
mic domain of the gp130 subunit. This in turn triggers signal-
ing cascades involving mitogen activated protein kinases
(MAPKs) and signal transducer and activator of transcription
(STAT) family, in particular STAT3 and STAT1 proteins,
resulting in the activation of transcription of speciﬁc genes
[4,5].
During the secretory phase of the menstrual cycle, human
endometrial stromal cells spontaneously differentiate into
decidualized stromal cells which are morphologically and bio-
chemically distinct. If pregnancy ensues, decidualization pro-
ceeds further and provides the maternally derived component
of the placenta. The molecular interactions that regulate the
formation, maintenance, and remodeling of decidua are poorly
understood although many factors are known to be involved
[6]. IL-11 is absolutely required for decidualization of endome-
trial stromal cells and blastocyst implantation in mice [7]. In
humans, IL-11 mRNA and protein are expressed in the endo-
metrium throughout the menstrual cycle, while its expression
in the stroma was reported to be restricted to the predecidual-
ized stromal cells in the late secretory phase to help the blasto-
cyst implantation. The expression of IL-11 and its receptor
(IL-11Ra) was found to be maximal during decidualization,
suggesting that their interactions in the decidua are important
in that process [3,6].
Leukemia inhibitory factor (LIF) derived its name from its
ability to induce the terminal differentiation of myeloid leuke-
mia cells, thus preventing their continued growth. One of the
main properties attributed to LIF is the regulation of embryo
implantation. LIF had been shown to facilitate implantation in
the mouse model and possibly in humans [8]. LIF is expressedin the luminal epithelium during the mid-late secretory phase
(days 18–28) of the menstrual cycle, supporting a role in
implantation [9]. It has been suggested that recombinant hu-
man LIF might help to improve the implantation rate in wo-
men with unexplained infertility [10]. Many in vitro
fertilization (IVF) studies using gene-matrix technology had
revealed some differences in the expression of many molecules,
cytokines, and other factors in endometrium of infertile wo-
men compared with fertile women [11,12].
The aim of the present study was to assess the levels of LIF,
IL-11, and IL-11 a receptor gene expression in the endome-
trium of women undergoing IVF and correlate their levels with
the IVF pregnancy outcome. Also, the study aimed to detect
any sequence mutation in these three genes among IVF preg-
nant and non-pregnant women versus control menstrual blood
of fertile women.
Methodology
Patients and tissues
Fifteen women were enrolled in the current study; they were
under IVF long protocol in The IVF Centre, Kasr El Aini
Hospital, Cairo University, Egypt. Patients fulﬁlled the inclu-
sion criteria that included the following: age between 23 and
35 years, FSH < 10 mIU/ml, no endometriosis, no previous
uterine operations, no history of poor response in previous
IVF cycles, no diabetes mellitus, and no antral follicle count
(AFC) > 5. All patients gave their written informed consent
to participate in the study.
Endometrial tissue samples were taken on the day of oo-
cyte retrieval using soft suction plastic catheter. The original
plane of this study was to take the endometrial biopsy twice
on day of pick up and on day of transfer (day 5 post-LH
surge), but we observed the occurrence of endometrial bleed-
ing, so we stopped the procedure and assess results by chem-
ical pregnancy rate. The pregnancy rate was 50% among the
done cases, but the IVF board reconsiders the biopsy at day
of pick up only. Standard long protocol was used. Down
regulation started on day 21 of the previous cycle using deca-
peptyl 0.1 mg sc daily till withdrawal occurs, serum E 2 done
on day 2 of cycle when less than 50 and endometrial thick-
ness less than 5, stimulation with 150–300 IU of HMG was
started. Folliculometry started 7 days then continued every
other day till more than 4 follicles of 18 mm size are seen,
and HCG 5000–10,000 iu GIVEN IM 36 hs before ovum
pick up all embryos were day 3 6–8 cell embryos. The men-
strual blood of 10 women with regular menstrual cycles and
with no apparent endometrial dysfunction was taken as
control samples. The study protocol and informed consents
were approved by the Human Ethics Committee of Cairo
University.
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Endometrial biopsies and menstrual control blood were lysed
by RLT buffer (QIAGEN, Germantown, MD). The lysates
were further prepared for total RNA extraction using the
RNeasy mini kit (QIAGEN, Germantown, MD) according
to the manufacturer’s instructions. DNase was applied to
avoid DNA contamination. The RNA extract was stored at
80 C until future use. RNA purity, yield, and concentration
were determined through dual spectrophotometry (Beckman,
USA), and 1 lg of RNA was run on a 1% agarose gel (Roche,
Castle Hill, Australia) to ensure integrity of the RNA.
Quantitative RT-PCR (qRT-PCR)
Reverse transcriptase (RT) reaction mixture using High
Capacity Reverse Transcriptase kit (Applied Biosystems,
USA) containing 1 lg total RNA from each sample for cDNA
synthesis, 0.5 lg random primer, 5 · RT buffer, 2.5 mmol/l
dNTP, 20 U RNase inhibitor, and 200 U MMLV reverse
transcriptase in a total volume of 25 ll was incubated at
37 C for 60 min then heated to 95 C for 5 min to inactivate
MMLV. Minus RT for each sample was applied as negative
control. RT was followed by qPCR, 50 ng of cDNA was added
to 5· Fast-Start SYBR green master mixes with Rox (Roche
Diagnostics, Indianapolis, IN) and 200 ng of primer mix (Sig-
ma). The reaction was carried out in micro-optical plates (Ap-
plied Biosystems) and analyzed using StepOne real-time PCR
system (Applied Biosystems). The PCR running method was
as follows: 10 min at 95 C for enzyme activation followed
by 40 cycles of 15 s at 95 C, 20 s at 55 C, and 30 s at 72 C
for the ampliﬁcation step. The primers used in the qRT-PCR
evaluation were speciﬁc for target genes (Table 1). Relative
mRNA expression was calculated by the comparative cycle
threshold method (DDCt) as outlined in the manufacturer’s
user manual with GAPDH housekeeping gene. The ﬂuores-
cence was plotted versus PCR cycle number for reaction,
and each sample was indicated.
Serum hormonal levels assay
FSH, LH, and E2 were estimated by ELISA according to
instructions of manufacturers.
DNA puriﬁcation and sequencing analysis
IL-11 and LIF genes were analyzed by direct sequencing of the
PCR products using SEQr kit (Applied Biosystems), accordingTable 1 The oligonucleotide primers sequence of the studied genes
Gene Primer sequence
IL-11 Forward: 50-TCTCTCCTGGCGGACA
Reverse: 50-AATCCAGGTTGTGGTCC
IL-11Ra Forward: 50-CACACCCTCGGCTACT
Reverse: 50-AAGAAAGGATTCCCAA
LIF Forward: 50-TGGTTCTGCACTGGAA
Reverse: 50-GTAATAGAGAATAAAG
GAPDH Forward: 50-CCTCTACTGGCGCTGC
Reverse: 50-GTCCACCACTGACACGTto manufacturer’s protocol. PCR products were puriﬁed using
the QIAquick Gel Extraction Kit (QIAGEN). The relevant
puriﬁed DNA samples of all the cases and controls were ampli-
ﬁed and sequenced using automated sequencing with the aid of
a Big Dye Terminator Sequencing Kit (PE/Applied Biosys-
tems, Foster City, CA). The samples were run in an automated
sequencer ABI Prism 310 Avant (PE/Applied Biosystems). All
samples were sequenced twice to ensure the results.
Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), median, and range. Comparison between
women who could achieve pregnancy and those who did not
was done using Mann Whitney U test for independent sam-
ples. Correlation between various variables was done using
Spearman rank correlation equation for non-normal variables.
P values < 0.05 were considered statistically signiﬁcant. All
statistical calculations were done using computer programs
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) version 15 for Microsoft Windows.
Results
There was a statistical signiﬁcant difference detected between
control group and studied cases group as regards the studied
cytokines genes expression levels but no signiﬁcant difference
as regards demographic data and hormonal levels (Table 2).
There was no statistical signiﬁcant difference detected be-
tween cases with IVF positive or negative pregnancy outcome
for demographic data, hormonal levels, and the studied cyto-
kines levels (Table 3).
There was no statistical signiﬁcant correlation between lev-
els of IL11, IL-11Ra, and LIF gene expression and other data
as age, FSH, LH, E2, and endometrial thickness (Table 4).
DNA sequence analysis results
mRNA expression for the three studied genes was quantitated
versus GAPDH as housekeeping gene. There were no statisti-
cal signiﬁcance differences between the three studied genes
expression quantitation. Blind DNA sequencing for PCR
products of IL-11 and LIF was done in order to ﬁnd possible
DNA sequence changes that allow occurrence of pregnancy or
not. There was DNA sequence transition from G (at IVF po-
sitive pregnancy cases) to T (at IVF negative pregnancy cases)
at nucleotide 365 for IL-11 gene (Fig. 1) and transition from C.
Gene accession number
CG-30 NT_011109.16
CC-30
TGAT-30 NT_008413.18
AGACG-30
ACATG-30 NT_011520.12
AGGGCATTGG-30
CAAGGCT-30 NT_009759.16
TGG-30
Table 3 Test for the difference between demographic and biochemical characteristics of patients with IVF negative and positive
pregnancy outcome.
Negative IVF pregnancy outcome (n= 10) Positive IVF pregnancy outcome (n= 5) p Value
Mean ± SD Median (range) Mean ± SD Median (range)
Age (years) 28.6 ± 4.0 28.0 (23.0–35.0) 30.0 ± 4.4 28.0 (27.0–35.0) 0.538
FSH (mIU/ml) 5.5 ± 1.3 6.0 (3.8–7.0) 5.8 ± 2.8 5.2 (3.4–9.4) 0.705
LH (mIU/ml) 5.7 ± 4.5 4.9 (1.0–15.0) 3.8 ± 1.5 3.5 (2.0–6.0) 0.450
E2 (pg/ml) 52.1 ± 8.9 49 (44.0–67.0) 46.7 ± 15.0 48.0 (31.0–61.0) 0.569
End. thickness (mm) 12.4 ± 1.6 12.0 (10.0–15.0) 11.0 ± 1.4 11.0 (9.0–13.0) 0.117
IL-11 12.5 ± 0.9 12.7 (11.4–13.9) 12.7 ± 0.6 12.9 (11.8–13.3) 0.667
IL-11Ra 9.7 ± 0.8 9.3 (8.7–11.2) 9.9 ± 1.0 9.7 (8.6–11.1) 0.539
LIF 12.3 ± 1.0 12.5 (10.6–13.3) 11.5 ± 0.8 11.6 (10.5–12.4) 0.140
FSH: Follicular stimulating hormone (mIU/ml), LH: Luteinizing hormone (mIU/ml), E2: Estradiol (pg/ml) and End. thickness: Endometrial
thickness (mm). p Value: indicates signiﬁcant value when < 0.05.
Table 4 Correlation between IL11, IL-11Ra, and LIF gene
expression and age, FSH, LH, E2, and endometrial thickness.
IL-11 IL-11 R LIF
Age
r 0.307 0.174 0.147
p 0.358 0.608 0.665
FSH
r 0.127 0.528 0.132
p 0.709 0.095 0.698
LH
r 0.182 0.323 0.151
p 0.593 0.332 0.658
E2
r 0.224 0.164 0.322
p 0.533 0.650 0.364
Endometrial thickness
r 0.260 0.086 0.409
p 0.349 0.760 0.130
r: Correlation coefﬁcient.
Fig. 1 DNA sequence analysis for IL-11 gene showed G to T
transition at nucleotide-365.
Fig. 2 DNA sequence analysis for LIF gene showed C to T
transition at nucleotide-351.
Table 2 Demographic and Biochemical characteristics of control and study groups.
Control group (n= 10) Study group (n= 15) p Value
Mean ± SD Median (range) Mean ± SD Median (range)
Age (years) 29.4 ± 5.0 29.0 (23.0–38.0) 29.0 ± 3.9 28.0 (23.0–35.0) 0.968
FSH (mIU/ml) 5.7 ± 0.8 5.6 (4.6–7.0) 5.6 ± 1.9 6.0 (3.4–9.4) 0.778
LH (mIU/ml) 4.1 ± 0.6 4.0 (3.2–5.0) 5.0 ± 3.7 4.2 (0.7–15.0) 0.904
IL-11 7.5 ± 0.3 7.5 (7.1–8.0) 11.3 ± 2.1 9.3 (6.3–13.3) <0.001
IL-11Ra 5.5 ± 0.4 5.5 (5.1–6.2) 9.1 ± 2.1 9.3 (4.5–11.2) 0.001
LIF 8.5 ± 0.2 8.5 (8.2–8.9) 11.7 ± 2.5 12.6 (5.3–13.9) 0.001
FSH: Follicular stimulating hormone, LH: Luteinizing hormone, and p value: signiﬁcant if < 0.05.
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nancy cases) at nucleotide 351 for LIF gene (Fig. 2). These se-
quence changes were compared to DNA sequence of studied
genes in control menstrual blood of fertile women, and they
were similar to DNA sequences of IVF positive pregnancy
cases. No DNA sequence change was detected for IL-11Ra
gene at both IVF positive and negative pregnancy cases.
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Implantation is a complex process, in which the foreign blasto-
cyst needs to be accepted by the maternal endometrium.
Allowance for that, extensive preparation and bidirectional
communication between the blastocyst and the endometrium
are required [13]. Implantation process encompasses several
distinct stages: apposition, adhesion, penetration, and tropho-
blast invasion. These steps can only take place during the win-
dow of implantation [14].
In human in vitro fertilization (IVF), embryo transfer can
be accompanied by a low implantation rate even after a very
successful IVF. The continuous tendency of improving implan-
tation rates is of prime importance. The economic problems
and psychological constraints linked to the necessity of under-
going multiple attempts before obtaining a successful preg-
nancy are a continuous worry for both medical practitioners
and economists. Further speciﬁc and detailed knowledge about
the molecule network that controls proper implantation is
needed to be known in such a perspective.
Many molecules play important roles in the events of
implantation such as adhesion molecules, chemokines, cyto-
kines, growth factors, and invasive proteinases [15]. Both inter-
leukin 11 (IL-11) and leukemia inhibitory factor (LIF) are two
of few cytokines known to be absolutely required for blasto-
cyst implantation, and both are obligatory for implantation
in mice [7].
In the current study, we conﬁrmed, by using quantitative
RT-PCR, that there were no signiﬁcant differences among
gene expression levels of LIF, IL-11, and IL-11Ra between
implantation versus non-implantation IVF.
In agreement with our results, Gazvani et al. [15] reported
that there was no signiﬁcant difference in IL-11 mRNA expres-
sion pattern in the peritoneal ﬂuid and the endometrium of fer-
tile and infertile women.
Additional conﬁrmation to our results was added by Miko-
lajczyk et al. [12] who showed no statistically signiﬁcant differ-
ences in uterine ﬂushing in infertile women (with and without
endometriosis) with regard to IL-11 and LIF levels when com-
pared to fertile controls. Their results were also conﬁrmed by
the results of RT-PCR, where there were no differences be-
tween studied groups.
However, the present results disagree with those reported
by Le´de´e-Bataille et al. [16] and Dimitriadis et al. [6,17] who
concluded that LIF, IL-11, and IL-11Ra mRNA and protein
are down-regulated in the endometrium of women with unex-
plained/idiopathic infertility or infertility and endometriosis
compared with that of fertile controls. Also, reduced IL-11
and LIF secretion by endometrial epithelial cells may be
responsible for the reduced implantation/pregnancy rates in
excessive ovarian responders during IVF treatment [18,19].
This contradiction between results may be reasonably ex-
plained due to the different techniques used, the different tim-
ings for endometrial sampling, or the number of patients
included in each study.
In the present study, changes in the sequences of IL-11 and
LIF DNA were detected at failed IVF pregnancy outcome
compared to DNA sequence for both genes of successful
IVF pregnancy outcome. While in IL-11Ra, no DNA sequence
changes were detected at both failed and successful IFV preg-
nancy outcomes.Female mice with a null mutation of the IL-11 are infertile
due to a defective post-implantation response to the implant-
ing blastocyst, whereas female mice with no functional LIF
gene are infertile due to an inability of normal embryos to im-
plant [7,20].
Mutation of LIF gene results in reproductive failure in LIF
/ mice due to an inability to implant their blastocysts. This
condition is reversed by infusion of LIF or by transfer of em-
bryos to pseudo-pregnant recipient of wild-type mice [21]. Kra-
lickova et al. [22] investigated the prevalence of the LIF gene
mutations in the population of infertile women that consisted
of nulligravid and secondary infertile patients. They revealed
that the frequency of functionally relevant mutations of the
LIF gene in infertile women is signiﬁcantly enhanced in com-
parison with fertile controls.
Certain studies suggested that LIF gene mutations contrib-
ute to embryo implantation failure and thus to infertility and
decreased pregnancy rates in Assisted Reproductive Technol-
ogy (ART) [22,23]. These results coincided with our suggestion
that the LIF gene mutations affect fertility.
The current work is just a pilot study, and a larger number
of infertile patients to be compared with fertile women are
needed for further investigations. Also, complete and detailed
understanding of the complex regulatory mechanisms may
provide new therapeutic targets for female infertility. Future
work should include stem cells from a patient with a gene de-
fect can be corrected, and scientists believe that when reintro-
duced into the patient, they could treat the effects of the
mutation causing the disease.Conclusions
Non signiﬁcant correlation was found between quantitative
mRNA of LIF, IL-11, and IL-11Ra gene expressions and IVF
pregnancy outcomes. IL-11 and LIF genes mutation may con-
tribute to IVF failure pregnancy outcomes. Our data may sus-
pect diagnosis of endometrial associated implantation failure.
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